The New York Times reports about a group of scientists and executives from the National Institutes of Health, the Food and Drug Administration, the drug and medical-imaging industries, universities, and nonprofit groups that joined in a collaborative effort to find the biological markers that show the progression of Alzheimer’s disease in the human brain.  Read more